Purpose The purpose of the study was to validate the Korean version of Cancer Survivors’ Unmet Needs (CaSUN) scale among non–small cell lung cancer survivors.
Materials and Methods Participants were recruited from outpatient clinics at the Samsung Medical Center in Seoul, South Korea, from January to October 2020. Participants completed a survey questionnaire that included the CaSUN. Exploratory and confirmatory factor analysis and Pearson’s correlations were used to evaluate the reliability and validity of the Korean version of the CaSUN (CaSUN-K). We also tested known-group validity using an independent t test or ANOVA.
Results In total, 949 provided informed consent and all of which completed the questionnaire. Among the 949 patients, 529 (55.7%) were male; the mean age and median time since the end of active treatment (standard deviation) was 63.4±8.8 years and the median was 18 months. Although the factor loadings were different from those for the original scale, the Cronbach’s alpha coefficients of the six domains in the CaSUN-K ranged from 0.68 to 0.95, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the CaSUN-K were high. Moderate correlations demonstrated the convergent validity of CaSUN-K with the relevant questionnaire. More than 60% of the participants reported information-related unmet needs, and the CaSUN-K discriminated between the needs reported by the different subgroups that we analyzed.
Conclusion The CaSUN-K is a reliable and valid measure for assessing the unmet needs in a cancer population, thus this tool help population to receive timely, targeted, and relevant care.
Citations
Citations to this article as recorded by
Supporting Life Adjustment in Patients With Lung Cancer Through a Comprehensive Care Program: Protocol for a Controlled Before-and-After Trial Wonyoung Jung, Alice Ahn, Genehee Lee, Sunga Kong, Danbee Kang, Dongok Lee, Tae Eun Kim, Young Mog Shim, Hong Kwan Kim, Jongho Cho, Juhee Cho, Dong Wook Shin JMIR Research Protocols.2024; 13: e54707. CrossRef
Validity and Reliability of a Simplified Chinese Version of Cancer Survivors' Unmet Needs Scale (CaSUN) Xiaojingyuan Xu, Xiaoyun Liang, Shiquan Yin Psycho-Oncology.2024;[Epub] CrossRef
Unmet Supportive Care Needs after Non-Small Cell Lung Cancer Resection at a Tertiary Hospital in Seoul, South Korea Junhee Park, Wonyoung Jung, Genehee Lee, Danbee Kang, Young Mog Shim, Hong Kwan Kim, Ansuk Jeong, Juhee Cho, Dong Wook Shin Healthcare.2023; 11(14): 2012. CrossRef
Kanserden Kurtulanların Karşılanmayan İhtiyaçları Ölçeğinin Türkçeye Uyarlanması: Geçerlik ve Güvenirlik Çalışması Gülyeter Erdoğan Yüce, Gamze Muz, Ayser Döner Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi.2023; 10(3): 264. CrossRef
Psychometric properties of the Slovenian version of the Cancer Survivors’ Unmet Needs (CaSUN-SL) measure in post-treatment cancer survivors Špela Miroševič, Polona Selič-Zupančič, Judith Prins, Vesna Homar, Zalika Klemenc-Ketiš BMC Psychology.2022;[Epub] CrossRef
Thi Xuan Mai Tran, So-Youn Jung, Eun-Gyeong Lee, Heeyoun Cho, Na Yeon Kim, Sungkeun Shim, Ho Young Kim, Danbee Kang, Juhee Cho, Eunsook Lee, Yoon Jung Chang, Hyunsoon Cho
Cancer Res Treat. 2022;54(4):1065-1073. Published online December 8, 2021
Purpose
Fear of cancer recurrence (FCR) is a common psychological issue in breast cancer (BC) survivors during early survivorship but whether the same is true among long-term survivors has yet to be empirically evaluated. This study investigated FCR level, its associated factors, and impact on quality of life (QoL) in long-term BC survivors.
Materials and Methods
Participants included women diagnosed with BC between 2004 and 2010 at two tertiary hospitals. Survey was conducted in 2020. The study measured FCR with the Fear of Cancer Recurrence Inventory and other patient-reported outcomes, including depression and cancer-related QoL. Logistic regression was used to identify factors associated with FCR, and structural equation modeling was conducted to explore the impact of FCR on other outcomes.
Results
Of 333 participants, the mean age at diagnosis was 45.5, and 46% experienced FCR. Age at diagnosis ≤ 45 (adjusted odds ratio [aOR], 2.64; 95% confidence interval [CI], 1.51 to 4.60), shorter time since diagnosis (aOR, 1.75, 95% CI, 1.08 to 2.89), and having a history of recurrence (aOR, 2.56; 95% CI, 1.16 to 5.65) was associated with more FCR. FCR was significantly associated with an increased risk of depression (β=0.471, p < 0.001) and negatively impacted emotional functioning (β=–0.531, p < 0.001). In addition, a higher FCR level may impair overall health-related QoL in long-term BC survivors (β=–0.108, p=0.021).
Conclusion
Ten years after diagnosis, long-term BC survivors still experienced a high level of FCR. Further, the negative impact of FCR on QoL and increased depression risk require an FCR screening and appropriate interventions to enhance long-term BC survivors' QoL.
Citations
Citations to this article as recorded by
CANCER. Is this Forever? Examining the Relationship Between Event Centrality and Fear of Cancer Recurrence from a Cognitive-Behavioral Standpoint Diana Todea, Andreea Luca, Ioana R. Podina Journal of Rational-Emotive & Cognitive-Behavior Therapy.2025;[Epub] CrossRef
Fear of the Cancer Coming Back: A Metasynthesis of Fear of Recurrence in Breast Cancer Kai‐Yue Wang, Hui Li, Nan Qin Public Health Nursing.2025; 42(1): 457. CrossRef
Social support, fear of cancer recurrence and sleep quality in breast cancer: A moderated network analysis Yingting Jiang, Xinyu Wu, Hongman Li, Ying Xiong, M. Tish Knobf, Zengjie Ye European Journal of Oncology Nursing.2025; 74: 102799. CrossRef
Dyadic effects of illness perception and maladaptive cognitive-emotional regulation strategies on the fear of cancer recurrence in breast cancer patients and spouses: an actor-partner interdependence mediation model Hui Ren, Tianye Yang, Songli Mei, Zhu Zhu, Jianjun Shi, Lingling Tong, Jia Yang, Yabin Sun BMC Psychiatry.2025;[Epub] CrossRef
Validating the Black Identity, Hair Product Use, and Breast Cancer Scale (BHBS) Among Black Breast Cancer Survivors Dede K. Teteh-Brooks, Marissa Ericson, Traci N. Bethea, Lenna Dawkins-Moultin, Nicole Sarkaria, Jared Bailey, Adana A. M. Llanos, Susanne Montgomery International Journal of Environmental Research and Public Health.2025; 22(2): 174. CrossRef
The Lived Experience of Suffering by Nigerian Female Breast Cancer Survivors: A Phenomenological Perspective Chinomso Ugochukwu Nwozichi, Margaret Olutosin Ojewale, Omolabake Salako, Deliverance Brotobor, Elizabeth Olaogun Journal of Patient Experience.2025;[Epub] CrossRef
Satisfaction with and perceived benefits of needs-assessment related to rehabilitation after chemotherapy among patients with breast cancer Marta Kramer Mikkelsen, Helle Elisabeth Jensen, Guri Spiegelhauer, Kirsten Amdi, Kasper Madsen, Kirstine Steen Nybom, Rikke Balschmidt Holm-Petersen, Dorte Nielsen Disability and Rehabilitation.2024; 46(12): 2548. CrossRef
Fear of recurrence in postoperative lung cancer patients: Trajectories, influencing factors and impacts on quality of life Xiaoyan Yang, Yonglin Li, Jialing Lin, Jianqing Zheng, Huimin Xiao, Weiti Chen, Feifei Huang Journal of Clinical Nursing.2024; 33(4): 1409. CrossRef
Unmet care needs of women who have undergone breast cancer surgery: A scoping review Qiaohong Ke, Fiona Timmins, Eileen Furlong, Diarmuid Stokes Journal of Advanced Nursing.2024; 80(5): 1732. CrossRef
Dyadic association between mindfulness, family avoidance of communication about cancer and fear of cancer recurrence among breast cancer couples: A cross-sectional study Xiangyu Zhao, Yunxue Zhang, Rui Qin, Guopeng Li, Xudong He, Xiaona Shen, Ping Li European Journal of Oncology Nursing.2024; 68: 102491. CrossRef
Prevalence and Factors Contributing to Fear of Recurrence in Breast Cancer Patients and Their Partners: A Cross-Sectional Study Ling Tong, Yuan Wang, Dewu Xu, Yibo Wu, Ling Chen International Journal of Women's Health.2024; Volume 16: 229. CrossRef
Fear of Cancer Progression: A Comparison between the Fear of Progression Questionnaire (FoP-Q-12) and the Concerns about Recurrence Questionnaire (CARQ-4) Andreas Hinz, Thomas Schulte, Anja Mehnert-Theuerkauf, Diana Richter, Annekathrin Sender, Hannah Brock, Michael Friedrich, Susanne Briest Healthcare.2024; 12(4): 435. CrossRef
Factors affecting the fear of recurrence in Breast cancer patients Dinara Kussainova, Anar Tursynbekova, Gulshara Aimbetova, Fatima Bagiyarova, Dilyara Kaidarova Research Journal of Pharmacy and Technology.2024; : 314. CrossRef
Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors: A Systematic Review Jacob Hampton, Ahmad Alam, Nicholas Zdenkowski, Christopher Rowe, Elizabeth Fradgley, Christine J. O'Neill Thyroid®.2024; 34(5): 541. CrossRef
Revisiting Combined Modality Therapy in Older Patients With Luminal Breast Cancer Through the Patient Lens Robert W. Mutter, Cynthia Chauhan, Matthew P. Goetz, Jean L. Wright Journal of Clinical Oncology.2024; 42(18): 2121. CrossRef
The impact of fear of cancer recurrence on the quality of life of breast cancer patients: A longitudinal study of the mediation effect of cortisol and hope Meidi Xiong, Yuping Cheng, Ying Luo, Chao Fang, Hongmei Yao, Qianqian Liu, Fang Lu, Xuan Li, Ziying Bie, Jinbing Bai, Chunhua Zhang European Journal of Oncology Nursing.2024; 70: 102600. CrossRef
Psychosocial factors associated with quality of life in cancer survivors: umbrella review Viktorya Voskanyan, Chiara Marzorati, Diana Sala, Roberto Grasso, Ricardo Pietrobon, Iris van der Heide, Merel Engelaar, Nanne Bos, Augusto Caraceni, Norbert Couspel, Montse Ferrer, Mogens Groenvold, Stein Kaasa, Claudio Lombardo, Aude Sirven, Hugo Vachon Journal of Cancer Research and Clinical Oncology.2024;[Epub] CrossRef
Enhancing Early-Stage Breast Cancer Survivorship: Evidence-Based Strategies, Surveillance Testing, and Imaging Guidelines Mitchell J. Elliott, Sherry Shen, Diana L. Lam, Thelma Brown, Marissa B. Lawson, Neil M. Iyengar, David W. Cescon American Society of Clinical Oncology Educational Book.2024;[Epub] CrossRef
Dyadic effects of financial toxicity and social support on the fear of cancer recurrence in breast cancer patients and caregivers: an actor–partner interdependence mediation model Hongyan Li, Yabin Sun, Tianye Yang, Xin Yin, Zhu Zhu, Jianjun Shi, Lingling Tong, Jia Yang, Hui Ren BMC Nursing.2024;[Epub] CrossRef
Understanding Reasons for Cancer Disparities in Italy: A Qualitative Study of Barriers and Needs of Cancer Patients and Healthcare Providers Giulia Ferraris, Veronica Coppini, Maria Vittoria Ferrari, Dario Monzani, Roberto Grasso, Gabriella Pravettoni Cancer Control.2024;[Epub] CrossRef
Latent profile analysis and related factors for fear of cancer recurrence among Chinese breast cancer patients in rehabilitation Yinjie Bai, Jing Zhang, Yujing Sun, Yingying Wang, Huangfei Xu European Journal of Oncology Nursing.2024; 71: 102651. CrossRef
Infographics on signs and symptoms of metastatic (secondary) breast cancer can empower women with a breast cancer diagnosis Nazanin Derakshan, Joanne Taylor, Bethany Chapman Frontiers in Psychology.2024;[Epub] CrossRef
Virtual body and emotions: A pilot study on the use of virtual reality for the management of unpleasant sensations after cancer Valeria Sebri, Ilaria Durosini, Milija Strika, Silvia Francesca Maria Pizzoli, Ketti Mazzocco, Gabriella Pravettoni Counselling and Psychotherapy Research.2024; 24(4): 1632. CrossRef
Correlation between symptom experience and fear of cancer recurrence in postoperative breast cancer patients undergoing chemotherapy in China: A cross-sectional study Manxia Han, Huaying Chen, Jialing Li, Xuemei Zheng, Xue Zhang, Lin Tao, Xiaoxia Zhang, Xianqiong Feng, Tim Luckett PLOS ONE.2024; 19(9): e0308907. CrossRef
Addressing the Arguments Against Omitting Radiotherapy After Breast-Conserving Surgery for Early Luminal Breast Cancers A. Maghous, I. Lalya, E. Marnouche, M. Hommadi, M. Belemlih, K. Andaloussi Saghir, M. Elmarjany, K. Hadadi, H. Sifat Indian Journal of Gynecologic Oncology.2024;[Epub] CrossRef
Fear of Cancer Recurrence and Unmet Needs in Triple Negative Breast Cancer Survivors Ka Ryeong Bae, So Hee Kim Asian Oncology Nursing.2024; 24(3): 125. CrossRef
Facilitating and Inhibiting Factors in Deciding to Start Retreatment in Survivors of Breast Cancer Recurrence Mahsa Matbouei, Majid Samsami, Mohsen Soleimani International Journal of Cancer Management.2023;[Epub] CrossRef
Adjuvant breast radiotherapy in patients aged 65 and over: Not a binary decision D. Azria, C. Bourgier, C. Lemanski Cancer/Radiothérapie.2023; 27(3): 181. CrossRef
Effects of CALM intervention on neutrophil-to-lymphocyte ratio (NLR), fear of cancer recurrence and quality of life in patients with lung cancer Jie Zhao, Menglian Wang, Runze Huang, Jian Xu, Chen Gan, Sheng Yu, Lingxue Tang, Senbang Yao, Wen Li, Huaidong Cheng Supportive Care in Cancer.2023;[Epub] CrossRef
Factors associated with health-related quality of life in a cohort of cancer survivors in New Jersey Sharon Manne, Katie Devine, Shawna Hudson, Deborah Kashy, Denalee O’Malley, Lisa E. Paddock, Elisa V. Bandera, Adana A. M. Llanos, Angela Fong, Neetu Singh, Sara Frederick, Andrew M. Evens BMC Cancer.2023;[Epub] CrossRef
Fear of cancer recurrence in South Korean survivors of breast cancer who have received adjuvant endocrine therapy: a cross-sectional study Seul Ki Park, Yul Ha Min Frontiers in Psychology.2023;[Epub] CrossRef
Altered regional homogeneity and homotopic connectivity in Chinese breast cancer survivors with fear of cancer recurrence: A resting-state fMRI study Li Peng, Xiaofei Hu, Chen Xu, Yuanyuan Xu, Han Lai, Ying Yang, Ju Liu, Yuan Xue, Min Li Journal of Psychosomatic Research.2023; 173: 111454. CrossRef
Protective Factors against Fear of Cancer Recurrence in Breast Cancer Patients: A Latent Growth Model Gabriella Bentley, Osnat Zamir, Rawan Dahabre, Shlomit Perry, Evangelos C. Karademas, Paula Poikonen-Saksela, Ketti Mazzocco, Berta Sousa, Ruth Pat-Horenczyk Cancers.2023; 15(18): 4590. CrossRef
Health-related quality of life in long-term early-stage breast cancer survivors compared to general population in Korea Thi Xuan Mai Tran, So-Youn Jung, Eun-Gyeong Lee, Heeyoun Cho, Na Yeon Kim, Sungkeun Shim, Ho Young Kim, Danbee Kang, Juhee Cho, Eunsook Lee, Yoonjung Chang, Hyunsoon Cho Journal of Cancer Survivorship.2023;[Epub] CrossRef
Cost-effectiveness versus treatment effectiveness: A radiation oncologist's dilemma in low-income and middle-income countries (LMIC) Priya Iyer The Lancet Regional Health - Southeast Asia.2022; 4: 100061. CrossRef
Sungkeun Shim, Danbee Kang, Nayeon Kim, Gayeon Han, Jihyun Lim, Hyunsoo Kim, Jeonghyun Park, Mankyung Lee, Jeong Eon Lee, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Jai Min Ryu, Seok Jin Nam, Se Kyung Lee, Juhee Cho
Cancer Res Treat. 2022;54(3):834-841. Published online October 13, 2021
Purpose Little is known about the impact of financial toxicity in disease-free breast cancer survivors. We aim to validate the COmprehensive Score for financial Toxicity in Korean (COST-K) and evaluate financial toxicity among disease-free breast cancer survivors.
Materials and Methods We conducted linguistic validation following a standardized methodology recommended by Functional Assessment of Chronic Illness Therapy multilingual translation (FACITtrans). For psychometric validation, we conducted a cross-sectional survey with 4,297 disease-free breast cancer survivors at a tertiary hospital in Seoul, Korea between November 2018 and April 2019. Survivors were asked to complete the COST-K and European Organization for Research and Treatment of Cancer Quality of Life Core 30 (EORTC QLQ-C30) questionnaires. The test-retest reliability, internal consistency, and validity of the COST-K were assessed using standard scale construction techniques.
Results The COST-K demonstrated good internal consistency, with a Cronbach’s α of 0.81. The test-retest analysis revealed an intraclass correlation coefficient of 0.78. The COST-K had moderate correlation (r=–0.60) with the financial difficulty item of the EORTC QLQ-C30 and week correlation with the items on acute and chronic symptom burdens (nausea/vomiting, –0.18; constipation, –0.14; diarrhea, –0.14), showing good convergent and divergent validity. The median COST-K was 27 (range, 0 to 44; mean±standard deivation [SD], 27.1±7.5) and about 30% and 5% of cancer survivors experienced mild and severe financial toxicity, respectively. Younger age, lower education, lower household income was associated with higher financial toxicity.
Conclusion The COST-K is a valid and reliable instrument for measuring financial toxicity in disease-free breast cancer survivors. Considering its impact on the health-related quality of life, more studies need to be conducted to evaluate financial toxicity in cancer survivors and design interventions.
Citations
Citations to this article as recorded by
Severity of Financial Toxicity for Patients Receiving Palliative Radiation Therapy Jeremy P. Harris, Eric Ku, Garrett Harada, Sophie Hsu, Elaine Chiao, Pranathi Rao, Erin Healy, Misako Nagasaka, Jessica Humphreys, Michael A. Hoyt American Journal of Hospice and Palliative Medicine®.2024; 41(6): 592. CrossRef
Financial Toxicity in Radiation Oncology: Impact for Our Patients and for Practicing Radiation Oncologists Victoria S. Wu, Xinglei Shen, Janet de Moor, Fumiko Chino, Jonathan Klein Advances in Radiation Oncology.2024; 9(3): 101419. CrossRef
Measures of financial toxicity in cancer survivors: a systematic review L. B. Thomy, M. Crichton, L. Jones, P. M. Yates, N. H. Hart, L. G. Collins, R. J. Chan Supportive Care in Cancer.2024;[Epub] CrossRef
Validation of the COmprehensive Score for Financial Toxicity (COST) in Vietnamese patients with cancer Binh Thang Tran, Dinh Duong Le, Thanh Gia Nguyen, Minh Tu Nguyen, Minh Hanh Nguyen, Cao Khoa Dang, Dinh Trung Tran, Le An Pham PLOS ONE.2024; 19(6): e0306339. CrossRef
Comprehensive Score for Financial Toxicity and Health-Related Quality of Life in Patients With Cancer and Survivors: A Systematic Review and Meta-Analysis Stevanus Pangestu, Fanni Rencz Value in Health.2023; 26(2): 300. CrossRef
Association between financial toxicity and health-related quality of life of patients with gynecologic cancer Yusuke Kajimoto, Kazunori Honda, Shiro Suzuki, Masahiko Mori, Hirofumi Tsubouchi, Kohshiro Nakao, Anri Azuma, Takashi Shibutani, Shoji Nagao, Takahiro Koyanagi, Izumi Kohara, Shuko Tamaki, Midori Yabuki, Lida Teng, Keiichi Fujiwara, Ataru Igarashi International Journal of Clinical Oncology.2023; 28(3): 454. CrossRef
Financial Toxicity Following Cancer in a Middle-Income Country with a Pluralistic Health System: Validation of the COST Questionnaire Veni V. Sakti, Mahmoud Danaee, Cheng-Har Yip, Ros S. A. Bustamam, Marniza Saad, Gin Gin Gan, Jerome Tan, Yueh Ni Lim, Flora L.T. Chong, Murallitharan Munisamy, Farahida Mohd Farid, Boon Lui Sew, Yek-Ching Kong, Nishalini Muniandy, Nirmala Bhoo-Pathy Cancer Care Research Online.2023; 3(3): e044. CrossRef
Financial Toxicity Among Breast Cancer Patients Yi Kuang, Xiaoyi Yuan, Zheng Zhu, Weijie Xing Cancer Nursing.2023;[Epub] CrossRef
Heterogeneity of financial toxicity and associated risk factors for older cancer survivors in China Mingzhu Su, Siqi Liu, Li Liu, Fang Wang, Jiahui Lao, Xiaojie Sun iScience.2023; 26(10): 107768. CrossRef
Evaluation of financial toxicity and associated factors in female patients with breast cancer: a systematic review and meta-analysis Yusuf Çeli̇k, Sevilay Şenol Çeli̇k, Seda Sarıköse, Hande Nur Arslan Supportive Care in Cancer.2023;[Epub] CrossRef
Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer Yusuke Kajimoto, Takashi Shibutani, Shoji Nagao, Satoshi Yamaguchi, Shiro Suzuki, Masahiko Mori, Hirofumi Tsubouchi, Kohshiro Nakao, Anri Azuma, Takahiro Koyanagi, Izumi Kohara, Shuko Tamaki, Midori Yabuki, Lida Teng, Kazunori Honda, Ataru Igarashi International Journal of Gynecologic Cancer.2022; : ijgc-2022-003410. CrossRef
Purpose The purpose of the study was to validate the Korean version of Patient-Reported Outcomes Measurement Information System 29 Profile v2.1 (K-PROMIS-29 V2.1) among cancer survivors.
Materials and Methods Participants were recruited from outpatient clinics of the Comprehensive Cancer Center at the Samsung Medical Center in Seoul, South Korea, from September to October 2018. Participants completed a survey questionnaire that included the K-PROMIS-29 V2.1 and the European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30). Principal component analysis and confirmatory factor analysis (CFA) and Pearson’s correlations were used to evaluate the reliability and validity of the K-PROMIS-29 V2.1.
Results The mean age of the study participants was 54.4 years, the mean time since diagnosis was 1.2 (±2.4) years, and 349 (87.3%) completed the entire questionnaire. The Cronbach’s alpha coefficients of the seven domains in the K-PROMIS-29 V2.1 ranged from 0.81 to 0.96, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the K-PROMIS-29 V2.1 were high (comparative fit index, 0.91 and standardized root-mean-squared residual, 0.06). High to moderate correlations were found between comparable subscales of the K-PROMIS-29 V2.1 and subscales of the EORTC QLQ-C30 (r=0.52-0.73).
Conclusion The K-PROMIS-29 V2.1 is a reliable and valid measure for assessing the health-related quality of life domains in a cancer population, thus supporting their use in studies and oncology trials.
Citations
Citations to this article as recorded by
Assessment of disease activity and quality of life of Korean patients with rheumatoid arthritis Young Ho Lee, Jae-Bum Jun Journal of Rheumatic Diseases.2025; 32(1): 3. CrossRef
Feasibility and Acceptability of Integrating Acupuncture for Management of Multiple Symptoms in Medically Underserved Breast Cancer Survivors Hongjin Li, Ardith Z. Doorenbos, Zhengjia Chen, Hannah Choi, Weiwei Ma, Oana Danciu, Crystal L. Patil, Shuang Gao, Natalie Lif, Judith M. Schlaeger Cancers.2025; 17(2): 304. CrossRef
Path analysis of illness uncertainty and psychosocial adaptation of patients with Marfan syndrome Sujin Kim, Yeonsoo Jang, JiYeon Choi, Kijun Song, Jae-kwan Song, Mona Choi European Journal of Cardiovascular Nursing.2024; 23(2): 197. CrossRef
A single-armed proof-of-concept study of Lymfit: A personalized, virtual exercise intervention to improve health outcomes in lymphoma survivors in the pandemic Christopher Angelillo, Wing Lam Tock, Matthew Salaciak, Ryan E. R. Reid, Ross E. Andersen, Christine Maheu, Nathalie A. Johnson, Miquel Vall-llosera Camps PLOS ONE.2024; 19(1): e0275038. CrossRef
Psychometric validation of the Functional Assessment of Cancer Therapy‐Endometrial among endometrial cancer patients Sooyeon Kim, Joseph J. Noh, Youngha Kim, Juhee Cho, Danbee Kang, Yoo‐Young Lee Cancer Medicine.2024;[Epub] CrossRef
Hungarian PROMIS-29+2: psychometric properties and population reference values Balázs Jenei, Alex Bató, Ariel Z. Mitev, Valentin Brodszky, Fanni Rencz Quality of Life Research.2023; 32(8): 2179. CrossRef
Preliminary evaluation of the Chinese version of the patient-reported outcomes measurement information system 29-item profile in patients with aortic dissection Wanbing Huang, Qiansheng Wu, Yufen Zhang, Chong Tian, Haishan Huang, Sufang Huang, Yanrong Zhou, Jing He, Hui Wang Health and Quality of Life Outcomes.2022;[Epub] CrossRef
Psychometric validation of the Korean version of PROMIS 29 Profile V2.1 among patients with lower extremity problems Youngha Kim, Danbee Kang, Eunjee Kang, Jihyun Lim, Sooyeon Kim, Heesu Nam, Sungkeun Shim, Mangyeong Lee, Young-Wan Moon, Seung-Jae Lim, Ki-Sun Sung, Juhee Cho BMC Sports Science, Medicine and Rehabilitation.2021;[Epub] CrossRef